Physician profile
Alexis Pascoe
NPI 1033776299
$5,421.56
in general payments reported to CMS, 2019-2025
11 companies · $107 in 2025
The $107 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $36.96 · 2021: $265 · 2022: $2,857 · 2023: $1,836 · 2024: $319 · 2025: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,295 · Travel and Lodging: $968.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,294.69 |
| Travel and Lodging | $967.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $2,719.63 | 2022-2023 | Envista Mx60 Iol |
| Alcon Vision LLC | $1,439.73 | 2020-2023 | Clareon, Centurion |
| Abbvie INC. | $450.99 | 2023-2025 | |
| Sight Sciences, INC. | $182.58 | 2022-2023 | Omni Surgical System |
| Carl Zeiss Meditec USA, INC. | $141.86 | 2023 | Quatera 700 |
| Regeneron Healthcare Solutions, INC. | $122.08 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $119.56 | 2020-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $104.74 | 2024 | Tecnis Iol |
| Genentech USA, INC. | $96.99 | 2022 | |
| Glaukos Corporation | $21.93 | 2021 | |
| Rxsight INC | $21.47 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexis Pascoe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.